Is that just a general statement or can you elaborate on which deals you consider to be poor and why?
There was the TEVA/Alergan deal.... which went sideways due to the generics market in US... it went sideways for everyone afaik?
Other than that....which other deals are "poor costly deals"?
I have a fair amount invested, so if I can get a better understanding of some details I may not know about that would be great, thanks.
MYX CHART, page-123
-
- There are more pages in this discussion • 415 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.57 |
Change
0.130(2.93%) |
Mkt cap ! $387.0M | |||
| Open | High | Low | Value | Volume |
| $4.44 | $4.60 | $4.44 | $135.9K | 29.87K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1295 | $4.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.58 | 105 | 2 |
View Market Depth
| Last trade - 11.22am 17/07/2024 (20 minute delay) ? |
| MYX (ASX) Chart |